![Robert Michael](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert Michael
Directeur Général chez ABBVIE INC.
Fortune : 17 M $ au 30/06/2024
Postes actifs de Robert Michael
Sociétés | Poste | Début | Fin |
---|---|---|---|
ABBVIE INC. | Directeur/Membre du Conseil | 01/07/2024 | - |
Directeur Général | 01/07/2024 | - | |
Comptroller/Controller/Auditor | 01/03/2017 | 19/10/2018 | |
Directeur des opérations | 29/06/2023 | 01/07/2024 | |
Directeur Financier/CFO | 19/10/2018 | 23/06/2022 | |
Corporate Officer/Principal | 01/01/2012 | 01/01/2013 | |
President | 23/06/2022 | 01/07/2024 | |
Treasurer | 01/01/2015 | 01/01/2016 | |
ALLERGAN PLC | Directeur/Membre du Conseil | 08/05/2020 | - |
President | 08/05/2020 | - | |
TOBIRA THERAPEUTICS INC | Directeur Général | - | - |
AbbVie Biotherapeutics Ltd.
![]() AbbVie Biotherapeutics Ltd. Financial ConglomeratesFinance Founded in 2016, AbbVie Biotherapeutics Ltd. is a British company that functions as an investment holding company. Part of AbbVie, Inc., the company is based in Maidenhead, UK. | Directeur/Membre du Conseil | 01/04/2019 | - |
Fremont Holding LLC
![]() Fremont Holding LLC Pharmaceuticals: MajorHealth Technology Fremont Holding LLC engages in provision of pharmaceutical services. The company is headquartered in North Chicago, IL. | Directeur Général | - | - |
Allergan GI Corp.
![]() Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Directeur/Membre du Conseil | - | - |
President | - | - | |
AbbVie Ltd. (United Kingdom)
![]() AbbVie Ltd. (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., AbbVie Ltd. (United Kingdom) is a British company that develops advanced therapies through research and innovation. The company is based in Maidenhead, UK and was founded in 2012. | Directeur des opérations | 01/01/2022 | - |
President | 01/01/2022 | - |
Historique de carrière de Robert Michael
Anciens postes connus de Robert Michael
Sociétés | Poste | Début | Fin |
---|---|---|---|
ABBOTT LABORATORIES | Corporate Officer/Principal | 01/02/1993 | 01/08/2012 |
Formation de Robert Michael
Kelley School of Business | Undergraduate Degree |
UCLA Anderson School of Management | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 9 |
Royaume-Uni | 3 |
Opérationnelle
President | 4 |
Director/Board Member | 4 |
Chief Executive Officer | 3 |
Sectorielle
Health Technology | 7 |
Consumer Services | 3 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
ABBVIE INC. | Health Technology |
ABBOTT LABORATORIES | Health Technology |
Entreprise privées | 6 |
---|---|
AbbVie Biotherapeutics Ltd.
![]() AbbVie Biotherapeutics Ltd. Financial ConglomeratesFinance Founded in 2016, AbbVie Biotherapeutics Ltd. is a British company that functions as an investment holding company. Part of AbbVie, Inc., the company is based in Maidenhead, UK. | Finance |
Fremont Holding LLC
![]() Fremont Holding LLC Pharmaceuticals: MajorHealth Technology Fremont Holding LLC engages in provision of pharmaceutical services. The company is headquartered in North Chicago, IL. | Health Technology |
Allergan Ltd. (Ireland)
![]() Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Tobira Therapeutics, Inc.
![]() Tobira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company was founded on September 11, 2006 and is headquartered in Madison, NJ. | Health Technology |
Allergan GI Corp.
![]() Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Health Technology |
AbbVie Ltd. (United Kingdom)
![]() AbbVie Ltd. (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., AbbVie Ltd. (United Kingdom) is a British company that develops advanced therapies through research and innovation. The company is based in Maidenhead, UK and was founded in 2012. | Commercial Services |
- Bourse
- Insiders
- Robert Michael
- Expérience